Virtify Partners with Forte Research Systems to Optimize Regulatory Disclosure Compliance Virtify® CTRR Integrates with OnCore® Enterprise Research System PR Newswire LEXINGTON, Mass. and MADISON, Wis., Sept. 25, 2013 LEXINGTON, Mass.and MADISON, Wis., Sept. 25, 2013 /PRNewswire/ --Virtify, Inc., a leading innovator in content and regulatory information solutions for the life sciences industry, and Forte Research Systems, Inc., a leading developer of specialized clinical trial management software, announced today the integration of Forte Research Systems' OnCore®Enterprise Research systemwith Virtify CTRR® (Clinical Trial Registration & Results). The integration of the two systems will optimize the submission process of clinical trials into the National Institute of Health's clinicaltrials.gov, ensuring compliance with disclosure requirements of the Food and Drug Administration Amendments Act (FDAAA). (Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO ) Virtify CTRR streamlines and automates the increasingly stringent mandatory registration and clinical results disclosure obligations to the National Institute of Health and other registries. Virtify CTRR eliminates duplicate data entry and polls Forte's OnCore hourly to ensure updated data between the two systems. Coupled with the benefits of the Virtify CTRR, OnCore becomes the most comprehensive solution available for seamless compliance with clinical trial disclosure requirements. "Virtify is pleased to partner with Forte, the acknowledged and most respected leader in clinical research management solutions for academic medical centers," said Dr. Satish Tadikonda, president and CEO of Virtify, Inc. "OnCore is a proven system that supports streamlined management of robust portfolios of clinical trials. The Forte partnership reflects Virtify's continued commitment to the academic medical center market, which has included a recent 3.2 version of CTRR and several academic customer wins." "Forte's partnerships are driven by our customers' needs and interests," said Brian Wulff, Vice President of Sales, Marketing & Partnerships at Forte. "Virtify is addressing an emerging regulatory compliance issue that impacts our customers. Forte is pleased to be able to offer, in conjunction with Virtify, a market leader in regulatory information management, an integration that assists with the operational efficiency and compliance of our shared customers." The OnCore system is Forte's flagship product and is the result of over a decade of experience working closely with world-class research organizations. It is used by more than 50 academic medical centers, research hospitals, and cancer centers. In today's environment of growing trial complexity and regulatory oversight, the need for a centralized system has never been greater. Learn more about the Virtify-Forte partnership at AACI Annual 2013, Washington, DC, Sept. 30-Oct. 2, 2013. About Forte Research Systems, Inc. Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops and markets clinical and translational research software for better research compliance, patient safety, operational efficiency, and financial viability. The company's flagship product, the OnCore® Enterprise Research solution, has been meeting the needs of academic medical centers, CTSAs, research hospitals, and cancer centers for over a dozen years. Now, its proven electronic data capture platform is available as a stand-alone hosted solution, Overture™ EDC. For Research Sites, Site Networks, and SMOs, Forte offers Allegro® CTMS. Forte is also host to the Clinical Research Blog and other resources for individuals interested in excellence in clinical research operations. About Virtify Virtify is the leading innovator in content and regulatory information management solutions for life sciences. Many of the world's leading organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's life science domain expertise has been leveraged by such companies as Genzyme/Sanofi, Novartis, Pfizer/Wyeth, Regeneron, academic research centers and CROs. Virtify's easy-to-use software suite is the industry's only solution to provide a secure, collaborative, web-based environment for managing regulated content throughout the entire continuum – from pre-clinical through product registration to commercialization. Visit us at http://www.virtify.com SOURCE Virtify, Inc. Website: http://www.virtify.com Contact: Eric Meyers, Virtify, Inc., 617-301-8710, email@example.com
Alibaba Opens at $92.70 per Share, IPO Priced at $68
Virtify Partners with Forte Research Systems to Optimize Regulatory Disclosure Compliance
Press spacebar to pause and continue. Press esc to stop.